CCG
CTSO icon

Cypress Capital Group’s Cytosorbents Corp CTSO Stock Holding History

Cypress Capital Group’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$80K – 267
2020
Q3 		$80K Sell
10,000
-8,000
-44% -$72.2K 0.01% 251
2020
Q2 		$178K Hold
18,000
– – 0.03% 238
2020
Q1 		$139K Buy
+18,000
New +$90.9K 0.03% 198

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cypress Capital Group's CTSO Position: Q4 2020 in Review

Cypress Capital Group sold out of Cytosorbents Corp (CTSO) in Q4 2020, closing a stake of 10,000 shares — an estimated $80K sold.

Cypress Capital Group first reported a position in CTSO in Q1 2020 and held it in 3 quarters. The position peaked at $178K in Q2 2020. 94 funds tracked by Wall St. Rank hold CTSO as of Q4 2020.

  • Cypress Capital Group reported no remaining Cytosorbents Corp position as of Q4 2020 after selling out during the quarter.
  • Cypress Capital Group sold 10,000 Cytosorbents Corp shares in Q4 2020, an estimated $80K.
  • Cypress Capital Group first reported a position in Cytosorbents Corp in Q1 2020 and held it in 3 quarters.
  • Cypress Capital Group's Cytosorbents Corp position peaked at $178K in Q2 2020.
  • 94 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2020.

Based on Cypress Capital Group's 13F filing for Q4 2020, filed 12 Jan 2021.